Healthcare provider profile · identity verified

Murat Gezen, MD

Hospitalist · LYNCHBURG, VA · NPI 1780668095

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	690	72
Atorvastatin Calcium	Atorvastatin Calcium	576	112
Eliquis	Apixaban	517	52
Donepezil Hcl	Donepezil Hcl	498	79
Amlodipine Besylate	Amlodipine Besylate	478	68
Quetiapine Fumarate	Quetiapine Fumarate	466	76
Memantine Hcl	Memantine Hcl	421	71
Furosemide	Furosemide	419	77
Trazodone Hcl	Trazodone Hcl	377	52
Escitalopram Oxalate	Escitalopram Oxalate	326	45
Sertraline Hcl	Sertraline Hcl	318	54
Pantoprazole Sodium	Pantoprazole Sodium	277	44
Famotidine	Famotidine	254	46
Metformin Hcl	Metformin Hcl	241	34
Buspirone Hcl	Buspirone Hcl	236	37
Losartan Potassium	Losartan Potassium	231	35
Potassium Chloride	Potassium Chloride	226	41
Lisinopril	Lisinopril	208	33
Omeprazole	Omeprazole	207	38
Latanoprost	Latanoprost	203	32
Clopidogrel	Clopidogrel Bisulfate	202	31
Gabapentin	Gabapentin	188	37
Mirtazapine	Mirtazapine	184	34
Metoprolol Tartrate	Metoprolol Tartrate	165	30
Tamsulosin Hcl	Tamsulosin Hcl	161	31
Meloxicam	Meloxicam	155	31
Carvedilol	Carvedilol	154	33
Levetiracetam	Levetiracetam	139	22
Metoprolol Succinate	Metoprolol Succinate	139	23
Duloxetine Hcl	Duloxetine Hcl	136	16
Cephalexin	Cephalexin	131	81
Risperidone	Risperidone	129	19
Allopurinol	Allopurinol	124	19
Fluticasone Propionate	Fluticasone Propionate	122	28
Simvastatin	Simvastatin	109	13
Baclofen	Baclofen	105	suppressed
Finasteride	Finasteride	97	17
Carbidopa-Levodopa	Carbidopa/Levodopa	93	16
Metformin Hcl Er	Metformin Hcl	92	15
Januvia	Sitagliptin Phosphate	91	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	84	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	82	suppressed
Nystatin	Nystatin	80	36
Hydralazine Hcl	Hydralazine Hcl	79	13
Rosuvastatin Calcium	Rosuvastatin Calcium	78	13
Citalopram Hbr	Citalopram Hydrobromide	77	12
Divalproex Sodium	Divalproex Sodium	73	16
Memantine Hcl Er	Memantine Hcl	72	suppressed
Entresto	Sacubitril/Valsartan	68	suppressed
Montelukast Sodium	Montelukast Sodium	66	suppressed
Midodrine Hcl	Midodrine Hcl	61	11
Prednisone	Prednisone	61	27
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	57	suppressed
Rivastigmine	Rivastigmine Tartrate	55	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	52	22
Nyamyc	Nystatin	52	32
Olanzapine	Olanzapine	52	suppressed
Tramadol Hcl	Tramadol Hcl	52	18
Ezetimibe	Ezetimibe	51	suppressed
Torsemide	Torsemide	51	suppressed
Atenolol	Atenolol	50	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	11
Hydrochlorothiazide	Hydrochlorothiazide	48	suppressed
Warfarin Sodium	Warfarin Sodium	47	suppressed
Bupropion Xl	Bupropion Hcl	46	11
Aripiprazole	Aripiprazole	45	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	45	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	45	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	45	suppressed
Farxiga	Dapagliflozin Propanediol	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	suppressed
Humalog	Insulin Lispro	44	suppressed
Timolol Maleate	Timolol Maleate	44	suppressed
Lorazepam	Lorazepam	43	20
Glimepiride	Glimepiride	38	suppressed
Glipizide	Glipizide	38	suppressed
Methenamine Hippurate	Methenamine Hippurate	37	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	35	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	35	suppressed
Spironolactone	Spironolactone	35	suppressed
Trulicity	Dulaglutide	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	27
Insulin Lispro	Insulin Lispro	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	31	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Erythromycin	Erythromycin Base	31	suppressed
Loperamide	Loperamide Hcl	31	23
Myrbetriq	Mirabegron	31	suppressed
Sucralfate	Sucralfate	31	suppressed
Valsartan	Valsartan	30	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	28	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	17
Lovastatin	Lovastatin	28	suppressed
Ramelteon	Ramelteon	28	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	21
Triamcinolone Acetonide	Triamcinolone Acetonide	27	15
Alendronate Sodium	Alendronate Sodium	26	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	26	suppressed
Rivastigmine	Rivastigmine	26	suppressed
Vraylar	Cariprazine Hcl	26	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Ibuprofen	Ibuprofen	25	12
Pregabalin	Pregabalin	25	suppressed
Ondansetron Odt	Ondansetron	24	18
Ranolazine Er	Ranolazine	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Letrozole	Letrozole	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Diazepam	Diazepam	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Humulin N	Insulin Nph Human Isophane	20	suppressed
Lumigan	Bimatoprost	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Valproic Acid	Valproic Acid	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Methimazole	Methimazole	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Estradiol	Estradiol	17	suppressed
Haloperidol Lactate	Haloperidol Lactate	17	14
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Cefdinir	Cefdinir	16	15
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Levofloxacin	Levofloxacin	16	14
Methotrexate	Methotrexate Sodium	16	suppressed
Oxcarbazepine	Oxcarbazepine	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Phenytek	Phenytoin Sodium Extended	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Fluconazole	Fluconazole	14	13
Lamotrigine	Lamotrigine	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	12
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Trimethoprim	Trimethoprim	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lidocaine Hcl	Lidocaine Hcl	13	11
Linzess	Linaclotide	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Nystop	Nystatin	13	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Easy Comfort Pen Needle	Pen Needle, Diabetic	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Novolin N	Insulin Nph Human Isophane	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	12
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Ramipril	Ramipril	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Single Use Swab	Alcohol Antiseptic Pads	12	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Ozempic	Semaglutide	11	suppressed
Silodosin	Silodosin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error